People who use GLP-1 weight loss drugs like Ozempic are more likely to suffer from severe acid reflux, or GERD, a new ...

According to a new feature by the Washington Post, approximately 16 million American adults are on GLP-1 drugs such as ...

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

A Trump administration proposal to consider another form of drugs for Medicare price cuts is spurring legal and policy ...

Massachusetts health insurers are effectively telling the drug companies that they may seek a rapidly growing customer base or charge unjustifiably high prices, but they can’t have both.

Insurers are cutting coverage, citing costs. But there’s seldom any discussion of the return on investment from these drugs ...

New rules are reshaping the telehealth market for GLP-1s like Ozempic and Wegovy, potentially impacting access to these drugs ...

Reduced monthly costs for uninsured patients still amount to around $500. That can put the drugs out of reach for many.

This is only a glimpse of the data available to CivicScience clients. Discover more data. It’s safe to say that GLP-1 ...

Some online pharmacies sell semaglutide and tirzepatide that are ineffective, unsafe, or an outright scam. Here’s how to find ...

The new arrangement could cut patients' copays to $25 per month, or less, for Wegovy, Zepbound, Ozempic and Rybelsus ...

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...